Articles with public access mandates - Dirk GrimmLearn more
Not available anywhere: 12
Engineered anti-CRISPR proteins for optogenetic control of CRISPR–Cas9
F Bubeck, MD Hoffmann, Z Harteveld, S Aschenbrenner, A Bietz, ...
Nature methods 15 (11), 924-927, 2018
Mandates: Swiss National Science Foundation, German Research Foundation, Helmholtz …
Next-generation AAV vectors for clinical use: an ever-accelerating race
J Weinmann, D Grimm
Virus Genes 53 (5), 707-713, 2017
Mandates: German Research Foundation, European Commission
Split Cas9, not hairs− advancing the therapeutic index of CRISPR technology
C Schmelas, D Grimm
Biotechnology Journal 13 (9), 1700432, 2018
Mandates: German Research Foundation, European Commission, Federal Ministry of …
High-throughput dissection of AAV–host interactions: the fast and the curious
AK Herrmann, D Grimm
Journal of molecular biology 430 (17), 2626-2640, 2018
Mandates: German Research Foundation, European Commission, Federal Ministry of …
Impact of the assembly-activating protein on molecular evolution of synthetic adeno-associated virus capsids
AK Herrmann, S Große, K Börner, C Krämer, E Wiedtke, M Gunkel, ...
Human gene therapy 30 (1), 21-35, 2019
Mandates: German Research Foundation, Federal Ministry of Education and Research, Germany
Rapid and simple screening of CRISPR guide RNAs (gRNAs) in cultured cells using adeno-associated viral (AAV) vectors
J Fakhiri, M Nickl, D Grimm
CRISPR Gene Editing: Methods and Protocols, 111-126, 2019
Mandates: German Research Foundation, Federal Ministry of Education and Research, Germany
Progress in bioengineering of myotropic adeno-associated viral gene therapy vectors
J Liu, TW Koay, O Maiakovska, M Zayas, D Grimm
Human Gene Therapy 34 (9-10), 350-364, 2023
Mandates: German Research Foundation, Federal Ministry of Education and Research, Germany
Distinct transduction of muscle tissue in mice after systemic delivery of AAVpo1 vectors
W Tulalamba, J Weinmann, QH Pham, J El Andari, T VandenDriessche, ...
Gene therapy 27 (3), 170-179, 2020
Mandates: Research Foundation (Flanders), German Research Foundation, European …
Boosters for adeno-associated virus (AAV) vector (r) evolution
J Szumska, D Grimm
Cytotherapy 25 (3), 254-260, 2023
Mandates: German Research Foundation, Federal Ministry of Education and Research, Germany
Lab-scale production of recombinant adeno-associated viruses (AAV) for expression of optogenetic elements
J Haar, C Krämer, D Grimm
Photoswitching Proteins: Methods and Protocols, 83-100, 2020
Mandates: German Research Foundation, European Commission, Federal Ministry of …
Enhanced transduction of P2X7-expressing cells with recombinant rAAV vectors
AM Mann, W Schäfer, S Adriouch, K Börner, D Grimm, I Braren, ...
The P2X7 Receptor: Methods and Protocols, 129-144, 2022
Mandates: German Research Foundation, Agence Nationale de la Recherche, Federal …
Non-enzymatic methane formation by aerobic organisms
L Ernst, B Steinfeld, T Klintzsch, D Grimm, I Bischofs, F Keppler
Mandates: German Research Foundation
Available somewhere: 95
In vitro and in vivo gene therapy vector evolution via multispecies interbreeding and retargeting of adeno-associated viruses
D Grimm, JS Lee, L Wang, T Desai, B Akache, TA Storm, MA Kay
Journal of virology 82 (12), 5887-5911, 2008
Mandates: US National Institutes of Health
Fate tracing of mature hepatocytes in mouse liver homeostasis and regeneration
Y Malato, S Naqvi, N Schürmann, R Ng, B Wang, J Zape, MA Kay, ...
The Journal of clinical investigation 121 (12), 4850-4860, 2011
Mandates: US National Institutes of Health
CRISPR/Cas9‐mediated genome engineering: an adeno‐associated viral (AAV) vector toolbox
E Senís, C Fatouros, S Große, E Wiedtke, D Niopek, AK Mueller, K Börner, ...
Biotechnology journal 9 (11), 1402-1412, 2014
Mandates: German Research Foundation
Loss of epigenetic information as a cause of mammalian aging
JH Yang, M Hayano, PT Griffin, JA Amorim, MS Bonkowski, ...
Cell 186 (2), 305-326. e27, 2023
Mandates: US National Institutes of Health, Human Frontier Science Program
Six RNA viruses and forty-one hosts: viral small RNAs and modulation of small RNA repertoires in vertebrate and invertebrate systems
P Parameswaran, E Sklan, C Wilkins, T Burgon, MA Samuel, R Lu, ...
PLoS pathogens 6 (2), e1000764, 2010
Mandates: US National Institutes of Health, German Research Foundation
Macrophage microRNA-155 promotes cardiac hypertrophy and failure
S Heymans, MF Corsten, W Verhesen, P Carai, REW Van Leeuwen, ...
Circulation 128 (13), 1420-1432, 2013
Mandates: Research Foundation (Flanders), British Heart Foundation
Expression of shRNA from a tissue-specific pol II promoter is an effective and safe RNAi therapeutic
JC Giering, D Grimm, TA Storm, MA Kay
Molecular therapy 16 (9), 1630-1636, 2008
Mandates: US National Institutes of Health
Argonaute proteins are key determinants of RNAi efficacy, toxicity, and persistence in the adult mouse liver
D Grimm, L Wang, JS Lee, N Schürmann, S Gu, K Börner, TA Storm, ...
The Journal of clinical investigation 120 (9), 3106-3119, 2010
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program